As a positive control for mutation detection, we sequenced EGFR exons 18–21 in 44 adenocarcinoma of the lung and found 2 (5%) with somatic delE746-A750 mutations, previously reported to be associated with gefitinib responsiveness. This evidence concerns the gene EGFR and lung adenocarcinoma.